1.52
price down icon1.94%   -0.03
after-market After Hours: 1.59 0.07 +4.61%
loading

Ventyx Biosciences Inc Stock (VTYX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
17.04%
41.77
50.35 57.95 57.15 42.55
Operating Income/Loss
17.04%
-41.77
-50.35 -57.95 -57.15 -42.55
Nonoperating Income/Loss
11.05%
3.196
3.593 3.924 3.894 3.621
Income/Loss From Continuing Operations Before Tax
17.44%
-38.57
-46.72 -54.03 -53.25 -38.93
Income/Loss From Continuing Operations After Tax
17.44%
-38.57
-46.72 -54.03 -53.25 -38.93
Net Income/Loss
17.50%
-38.57
-46.75 -54.03 -53.25 -38.93
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
34,288%
61.83
0.1798 58.88 58.56 57.64
Diluted Average Shares
34,288%
61.83
0.1798 58.88 58.56 57.64
Basic Earnings Per Share
21.52%
-0.62
-0.79 -0.92 -0.91 -0.68
Diluted Earnings Per Share
21.52%
-0.62
-0.79 -0.92 -0.91 -0.68
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):